tci Medicare Compliance & Reimbursement - 2003 Issue 33

Pharmaceuticals: DRUGMAKERS SADDLED WITH PRICE-CHANGE LIMITS

There's good news and bad news for drugmakers in new rules on Medicaid rebates. Drugmakers will soon be subject to a three-year time limit for submitting drug pricing changes under the Medicaid rebate program. That's the upshot of a final rule the Centers for Medicare & Medicaid Services released Aug. 29. The rule - which finalizes two provisions of a proposal that's been on the books since 1995 - aims to set up procedural requirements relating to drugmakers' recordkeeping and pricing activities. The procedural changes are designed to ease the administrative burden on state Medicaid agencies. The bad news...

To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.


Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4200 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
Access to this feature is available in the following products:
  • tci Medicare Compliance & Reimbursement +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.